GSK News and Press, GlaxoSmithKline PLC From 05/27/24

2024-05-27 01:45:30 ET Summary Gilead is sitting at one of the lowest valuations in the Big Pharma sector, with a high and sustainable 4.6% dividend yield available for new buyers. The stock has an enviable track record of rising strongly in price when turmoil hits Wall Street and...

2024-05-24 10:00:00 ET Summary Dodge & Cox Stock Fund seeks long-term growth of principal and income, with a secondary focus on achieving a reasonable current income. During the first quarter of 2024, international equities performed well, especially in developed markets....

2024-05-24 07:00:00 ET Summary Dodge & Cox Stock Fund seeks long-term growth of principal and income, with a secondary focus on achieving a reasonable current income. Global equity markets achieved all-time highs during the first quarter of 2024, with the MSCI ACWI up 8.2...

2024-05-23 16:47:14 ET Summary CureVac N.V. is developing an avian influenza [H5N1] vaccine with GSK plc; A phase 1 study is already underway to evaluate this vaccine. It is working on a seasonal influenza vaccine, but further optimization is needed to target influenza B; Dose-opt...

2024-05-23 13:35:01 ET GSK faces another Zantac whistleblower lawsuit Pfizer agrees to pay up to $250M to settle Zantac cancer lawsuits - report Sanofi reportedly settles 4K Zantac cases for $100M GSK settles another Zantac lawsuit in California ...

2024-05-22 18:09:14 ET More on Moderna, Pfizer, etc. The Prognosis For Pfizer Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs Aggressive Strides Forward For Moderna's Cancer Vaccine Moderna, BioNTech close with double-digit perc...

2024-05-22 17:43:22 ET Several vaccine makers closed Wednesday up with double-digit percentage gains amid a report of the first avian flu case in a human in Australia and a second case in the U.S.... Read the full article on Seeking Alpha For further details see: Moderna...

2024-05-22 11:19:16 ET Summary GSK plc has advanced asthma care with their innovative depemokimab therapy, which is an IL-5 inhibitor and offers a long-acting option for severe asthma. Depemokimab demonstrated a significant reduction in asthma exacerbations over 52 weeks in clinic...

2024-05-22 11:07:09 ET More on CureVac BV, GSK, etc. GSK plc (GSK) Q1 2024 Earnings Call Transcript CureVac N.V. (CVAC) Q4 2023 Earnings Call Transcript CureVac N.V. 2023 Q4 - Results - Earnings Call Presentation GSK succeeds in late-stage trials for asthma c...

2024-05-21 08:32:53 ET More on GSK GSK plc (GSK) Q1 2024 Earnings Call Transcript GSK Trades At Low Price Multiples, But Its Pipeline Needs To Improve GSK plc (GSK) TD Cowen 44th Annual Health Care Conference (Transcript) GSK faces another Zantac whistleblowe...